The primary objective of this course is to provide you with a comprehensive understanding of the significant economic, strategic, and regulatory aspects involved in financing innovations within the healthcare industry. In the first half of the course, you will be introduced to the risk-return pro les and market failures specific to the biopharma industry. Additionally, we will explore the integral roles played by various financing channels, including government funding, non-pro t organizations, venture capital, and mergers and acquisitions, in driving the innovation process. The second half of the course will focus on examining the distinctive financial characteristics of U.S. hospitals and analyzing how external financing impacts healthcare quality and technology adoption.
Division: Finance
Center/Program: Healthcare & Pharmaceutical Management Program
Curriculum Pathway: Healthcare

Spring 2025


B8356 - 001

Spring 2024


B8356 - 001